OXFORD NANOIMAGING LIMITED - Profile & Financials

Accounts Submitted 3 Mar 2025

Confirmation Statement Submitted 11 Jul 2025

Net assets £32.33M £17.32M 2023 year on year

Total assets £37.62M £18.04M 2023 year on year

Total Liabilities £5.29M £713.31K 2023 year on year

Charges 1

1 outstanding

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Linacre House Jordan Hill Business Park Banbury Road Oxford OX2 8TA England

Telephone

0186 550 4599

rjorand@oni.bio

Website

oni.bio

Credit Report

Discover OXFORD NANOIMAGING LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2023

Type Total Exemption Full

Next accounts 31 December 2024

Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2018–2023)

Cash in Bank

£27.97M

Decreased by £19.13M (-41%)

Net Assets

£32.33M

Decreased by £17.32M (-35%)

Total Liabilities

£5.29M

Decreased by £713.31k (-12%)

Turnover

£5.73M

Increased by £55.12k (+1%)

Employees

Decreased by 3 (-3%)

Debt Ratio

14%

Increased by 3 (+27%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2023 Dec Year End	2022 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

£111k awarded

Show:

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

26 Allotments 273,769,152 Shares £64.38m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
23 Dec 2021	ORDINARY	6,120,000	£61.2	£0
22 Dec 2021	ORDINARY	6,043,000	£60.43	£0
21 Dec 2021	SERIES B	261,415,129	£56.66m	£0.217
4 Nov 2021	ORDINARY	75	£0.75	£0.01
29 Oct 2021	ORDINARY	447	£4.47	£0.01

Officers

7 active 20 resigned

Show resigned officers

						Status
Alex Parker	Director	American	United States	59	17 May 2025	Active
Alexander Aravanis	Director	American	United States	50	3 Nov 2023	Active
Ekaterina Smirnyagina	Director	French	United Kingdom	59	20 Dec 2022	Active
Keith Lawrence Crandell	Director	American	United States	65	21 Dec 2021	Active
Patrick John Finn	Director	American	United States	54	15 Dec 2020	Active
Paul Albert Scagnetti	Director	American	United States	58	8 Mar 2023	Active
Paul Scagnetti	Secretary	Unknown	Unknown	—	21 Mar 2023	Active

Shareholders

Shareholders (102)


Yaoyao Xiong	0.0%	214,000	Ordinary	11 Jul 2025
Zehra Nizami	0.0%	39,000	Ordinary	11 Jul 2025
William Pascoe	0.0%	14,000	Ordinary	11 Jul 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Oxford Sciences Innovation Plc

United Kingdom

Active

Notified 5 May 2016

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent

See All Controllers

Group Structure

OXFORD SCIENCE ENTERPRISES PLC united kingdom

OXFORD NANOIMAGING LIMITED Current Company

Charges

1 outstanding

Documents

Company Filings

Date	Category	Description	Document
2 Dec 2025	Officers	Appointment of Paul Albert Scagnetti as director	View(5 pages)
11 Jul 2025	Confirmation Statement	Confirmation statement made on 2025-06-30 with updates	View(13 pages)
3 Jun 2025	Officers	Appointment of Dr Alex Parker as director on 2025-05-17	View(2 pages)
3 Jun 2025	Officers	Termination of Sean Mackay as director on 2025-05-27	View(1 page)
5 Mar 2025	Gazette	Gazette Filings Brought Up To Date	View(1 page)